Artisan Partners Limited Partnership raised its holdings in Avidity Biosciences by 46.5% in the 1st quarter.

Source: https://www.americanbankingnews.com/2023/11/05/raymond-james-associates-has-925000-stock-holdings-in-avidity-biosciences-inc-nasdaqrna.html

Avidity Biosciences is advancing highly intriguing next-generation RNA medicines.

Source: https://seekingalpha.com/article/4596207-avidity-an-interesting-diversification?source=feed_all_articles

Avidity Partners Management LP bought a new stake in shares of Karyopharm Therapeutics during the 4th quarter valued at $32,755,000.

Source: https://www.etfdailynews.com/2023/08/08/barclays-plc-grows-stock-position-in-karyopharm-therapeutics-inc-nasdaqkpti/

Avidity Partners Management LP now owns 3,275,000 shares of the biotechnology company’s stock worth $72,672,000 after buying an additional 675,000 shares during the last quarter.

Source: https://www.americanbankingnews.com/2023/08/24/avidity-biosciences-inc-nasdaqrna-stake-raised-by-artisan-partners-limited-partnership.html